| LXRX Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the LXRX shares outstanding history going back to 5/21/2015:
Also see: LXRX Market Cap History LXRX YTD Return |
LXRX Shares Outstanding History — Lexicon Pharmaceuticals Share Count Over Time
As of 5/4/2026 Lexicon Pharmaceuticals has 444.20 million LXRX shares outstanding. Investors often track the LXRX shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows LXRX share count trends over time, with 43 historical shares outstanding datapoints presented, dating back to 5/21/2015.
| LXRX Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
LXRX Historical Shares Outstanding: +14.20% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| LXRX Stock Price Chart |
| About Lexicon Pharmaceuticals, Inc. |
| Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company. Co. is focused on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. Co. pipeline includes INPEFA (sotagliflozin), LX9211, and LX9851. Sotagliflozin is an orally delivered small molecule compound that is being developed for the treatment of heart failure and type I diabetes, and type II diabetes mellitus, chronic kidney disease and other cardiovascular risk factors. LX9211 is an orally delivered small molecule compound that is being developed for the treatment of neuropathic pain. We show 43 historical shares outstanding datapoints in our coverage of LXRX's shares outstanding history. Understanding the changing numbers of LXRX shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like LXRX versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching LXRX by allowing them to research LXRX shares outstanding history as well as any other stock in our coverage universe. |
| LXRX Current Stock Quote |
Quotes delayed 20 minutes  Free LXRX Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| LXRX Share Performance |
| Shares Outstanding Peers |
| Lexicon Pharmaceuticals (LXRX) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
LYEL Shares Outstanding History LYRA Shares Outstanding History MACK Shares Outstanding History MASI Shares Outstanding History MBIO Shares Outstanding History MBOT Shares Outstanding History MBRX Shares Outstanding History MBVX Shares Outstanding History MCK Shares Outstanding History MCRB Shares Outstanding History More Healthcare companies » |
LXRX Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
